NCT06661603 Effect of Practicing Yoga and Meditation on Cortisol Hormone, Immunoglobulin A and Metabolic Parameter Among Medical Students
| NCT ID | NCT06661603 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Pecs |
| Condition | Healthy |
| Study Type | INTERVENTIONAL |
| Enrollment | 280 participants |
| Start Date | 2022-02-07 |
| Primary Completion | 2025-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 280 participants in total. It began in 2022-02-07 with a primary completion date of 2025-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This clinical trial aims to develop and test a yoga intervention to improve cortisol hormone rhythm, immunoglobulin A, and metabolic markers among medical students. The development of the yoga protocol, "GSY Goodbye Stress with Yoga Proto-col," was a collaborative effort involving a certified yoga trainer, medical researcher, and experienced yogis from India. GSY yoga intervention, which includes yoga asanas poses, breathing techniques, and guided meditation, may reduce stress levels, improve immunity, and enhance other metabolic parameters in medical students.
Eligibility Criteria
Inclusion Criteria: The inclusion criteria for the study required participants to be currently enrolled in the Medicine Faculty of the University of Pecs Exclusion Criteria: Students with illnesses (such as recent injuries, chronic pain, or significant arthritis) that would make it unsafe for them to take part in a yoga intervention will be excluded from the study.
Contact & Investigator
Shalini Chauhan
PRINCIPAL INVESTIGATOR
Assistant Professor, PhD student University of Pécs
Frequently Asked Questions
Who can join the NCT06661603 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 40 Years, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06661603 currently recruiting?
Yes, NCT06661603 is actively recruiting participants. Contact the research team at doktoriiskola@etk.pte.hu for enrollment information.
Where is the NCT06661603 trial being conducted?
This trial is being conducted at Pécs, Hungary.
Who is sponsoring the NCT06661603 clinical trial?
NCT06661603 is sponsored by University of Pecs. The principal investigator is Shalini Chauhan at Assistant Professor, PhD student University of Pécs. The trial plans to enroll 280 participants.